Barbagallo M, Ortu A, Spadini E, Salvadori A, Ampollini L, Internullo E, Ziegler S, Fanelli G. Respir Care. 2012 Sep;57(9):1418-24
Randomised trial of 50 patients allocated to receive either continuous oxygen therapy or two cycles of helmet CPAP for 120 minutes. Results suggest that by the end of the second helmet treatment, patient's had a significantly higher PaO2/FiO2 but the improvement in oxygenation was not lasting. However, helmet CPAP was 'secure and well tolerated'.
Link to abstract.
Conti G, Cavaliere F, Costa R, Craba A, Catarci S, Festa V, Proietti R, Antonelli M. Respir Care. 2007 Nov;52(11):1463-71
Comparison of the efficacy of NPPV delivered to 25 patients via helmet, matched with 25 controls chosen from historical patients treated with face mask. Authors conclude that NPPV by helmet can be 'an alternative to conventional ventilation'.
Link to abstract.
Squadrone V, Coha M, Cerutti E, Schellino MM, Biolino P, Occella P, Belloni G, Vilianis G, Fiore G, Cavallo F, Ranieri VM. JAMA. 2005 Feb 2;293(5):589-95
Randomised, controlled, unblinded study on 209 patients randomyl assigned to receive oxygen or oxygen plus CPAP via helmet. Primary end point was incidence of endotracheal intubation. Authors conclude that CPAP via helmet 'may decrease the incidence of endotracheal intubation' in this scenario.
Link to abstract.